Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

Por Hoang, David T, Iczkowski, Kenneth A, Kilari, Deepak, See, William, Nevalainen, Marja T
Publicado no Oncotarget (2016)

MicroRNAs can regulate human APP levels

Por Patel, Neha, Hoang, David, Miller, Nathan, Ansaloni, Sara, Huang, Qihong, Rogers, Jack T, Lee, Jeremy C, Saunders, Aleister J
Publicado em 2008

mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer

Por Schiewer, Matthew J, Den, Robert, Hoang, David T, Augello, Michael A, Lawrence, Yaacov R, Dicker, Adam P, Knudsen, Karen E
Publicado em 2012

PHARMACOLOGICAL SUPPRESSION OF JAK1/2 BY JAK1/2 INHIBITOR AZD1480 POTENTLY INHIBITS IL-6-INDUCED EXPERIMENTAL PROSTATE CANCER METASTASES FORMATION

Por Gu, Lei, Talati, Pooja, Vogiatzi, Paraskevi, Romero-Weaver, Ana L., Abdulghani, Junaid, Liao, Zhiyong, Leiby, Benjamin, Hoang, David T., Mirtti, Tuomas, Alanen, Kalle, Zinda, Michael, Huszar, Dennis, Nevalainen, Marja T.
Publicado em 2014

Inhibition of Stat5a/b enhances proteasomal degradation of androgen receptor liganded by antiandrogens in prostate cancer

Por Hoang, David T., Gu, Lei, Liao, Zhiyong, Talati, Pooja G., Shen, Feng, Koptyra, Mateusz, Tan, Shyh-Han, Ellsworth, Elyse, Gupta, Shilpa, Montie, Heather, Dagvadorj, Ayush, Savolainen, Saija, Leiby, Benjamin, Mirtti, Tuomas, Merry, Diane E., Nevalainen, Marja T.
Publicado no Mol Cancer Ther (2014)

Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer

Por Talati, Pooja G., Gu, Lei, Ellsworth, Elyse M., Girondo, Melanie A., Trerotola, Marco, Hoang, David T., Leiby, Benjamin, Dagvadorj, Ayush, McCue, Peter A., Lallas, Costas D., Trabulsi, Edouard J., Gomella, Leonard, Aplin, Andrew E., Languino, Lucia, Fatatis, Alessandro, Rui, Hallgeir, Nevalainen, Marja T.
Publicado no Am J Pathol (2015)

STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression

Por Haddad, Bassem R., Gu, Lei, Mirtti, Tuomas, Dagvadorj, Ayush, Vogiatzi, Paraskevi, Hoang, David T., Bajaj, Renu, Leiby, Benjamin, Ellsworth, Elyse, Blackmon, Shauna, Ruiz, Christian, Curtis, Mark, Fortina, Paolo, Ertel, Adam, Liu, Chengbao, Rui, Hallgeir, Visakorpi, Tapio, Bubendorf, Lukas, Lallas, Costas D., Trabulsi, Edouard J., McCue, Peter, Gomella, Leonard, Nevalainen, Marja T.
Publicado em 2013

Novel MicroRNA Candidates and miRNA-mRNA Pairs in Embryonic Stem (ES) Cells

Por Gu, Peili, Reid, Jeffrey G., Gao, Xiaolian, Shaw, Chad A., Creighton, Chad, Tran, Peter L., Zhou, Xiaochuan, Drabek, Rafal B., Steffen, David L., Hoang, David M., Weiss, Michelle K., Naghavi, Arash O., El-daye, Jad, Khan, Mahjabeen F., Legge, Glen B., Wheeler, David A., Gibbs, Richard A., Miller, Jonathan N., Cooney, Austin J., Gunaratne, Preethi H.
Publicado em 2008

Structure-based screen identifies a potent small-molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia

Por Liao, Zhiyong, Gu, Lei, Vergalli, Jenny, Mariani, Samanta A., De Dominici, Marco, Lokareddy, Ravi K., Dagvadorj, Ayush, Purushottamachar, Puranik, McCue, Peter A., Trabulsi, Edouard, Lallas, Costas D., Gupta, Shilpa, Ellsworth, Elyse, Blackmon, Shauna, Ertel, Adam, Fortina, Paolo, Leiby, Benjamin, Xia, Guanjun, Rui, Hallgeir, Hoang, David T., Gomella, Leonard G., Cingolani, Gino, Njar, Vincent, Pattabiraman, Nagarajan, Calabretta, Bruno, Nevalainen, Marja T.
Publicado no Mol Cancer Ther (2015)